Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI

Bert-Ram Sah, Soleen Ghafoor, Irene A. Burger, Edwin E.G.W. ter Voert, Tetsuro Sekine, Gaspar Delso, Martin Huellner, Konstantin J. Dedes, Andreas Boss and Patrick Veit-Haibach
Journal of Nuclear Medicine December 2018, 59 (12) 1817-1822; DOI: https://doi.org/10.2967/jnumed.118.209007
Bert-Ram Sah
1Department of Nuclear Medicine, University Hospital of Zurich, Zurich, Switzerland
2Department of Cancer Imaging, King`s College London, London, United Kingdom
3Department of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland
4University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soleen Ghafoor
3Department of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland
4University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene A. Burger
1Department of Nuclear Medicine, University Hospital of Zurich, Zurich, Switzerland
4University of Zurich, Zurich, Switzerland
5Cancer Center Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edwin E.G.W. ter Voert
1Department of Nuclear Medicine, University Hospital of Zurich, Zurich, Switzerland
4University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuro Sekine
1Department of Nuclear Medicine, University Hospital of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaspar Delso
1Department of Nuclear Medicine, University Hospital of Zurich, Zurich, Switzerland
6GE Healthcare, Waukesha, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Huellner
1Department of Nuclear Medicine, University Hospital of Zurich, Zurich, Switzerland
4University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantin J. Dedes
5Cancer Center Zurich, Zurich, Switzerland
7Department of Gynaecology, University Hospital of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Boss
3Department of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland
4University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Veit-Haibach
1Department of Nuclear Medicine, University Hospital of Zurich, Zurich, Switzerland
3Department of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland
4University of Zurich, Zurich, Switzerland
8Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada; and
9University of Toronto, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 59 no. 12 1817-1822
DOI 
https://doi.org/10.2967/jnumed.118.209007
PubMed 
29880506

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication January 30, 2018
  • Accepted for publication April 27, 2018
  • Published online December 3, 2018.

Article Versions

  • previous version (June 7, 2018 - 08:01).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Bert-Ram Sah1–4,
  2. Soleen Ghafoor3,4,
  3. Irene A. Burger1,4,5,
  4. Edwin E.G.W. ter Voert1,4,
  5. Tetsuro Sekine1,
  6. Gaspar Delso1,6,
  7. Martin Huellner1,4,
  8. Konstantin J. Dedes5,7,
  9. Andreas Boss3,4 and
  10. Patrick Veit-Haibach1,3,4,8,9
  1. 1Department of Nuclear Medicine, University Hospital of Zurich, Zurich, Switzerland
  2. 2Department of Cancer Imaging, King`s College London, London, United Kingdom
  3. 3Department of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland
  4. 4University of Zurich, Zurich, Switzerland
  5. 5Cancer Center Zurich, Zurich, Switzerland
  6. 6GE Healthcare, Waukesha, Wisconsin
  7. 7Department of Gynaecology, University Hospital of Zurich, Zurich, Switzerland
  8. 8Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada; and
  9. 9University of Toronto, Toronto, Ontario, Canada
  1. For correspondence or reprints contact: Bert-Ram Sah, Department of Nuclear Medicine, Department of Diagnostic and Interventional Radiology, University Hospital of Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland. E-mail: bert-ram.sah{at}usz.ch
View Full Text

Statistics from Altmetric.com

Cited By...

  • 15 Citations
  • 13 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Clinical advances in PET–MRI for breast cancer
    Amy M Fowler, Roberta M Strigel
    The Lancet Oncology 2022 23 1
  • Convolutional neural networks for improving image quality with noisy PET data
    Josh Schaefferkoetter, Jianhua Yan, Claudia Ortega, Andrew Sertic, Eli Lechtman, Yael Eshet, Ur Metser, Patrick Veit-Haibach
    EJNMMI Research 2020 10 1
  • Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [18F]-FDG PET/CT
    Ian Alberts, Christos Sachpekidis, George Prenosil, Marco Viscione, Karl Peter Bohn, Clemens Mingels, Kuangyu Shi, Ali Ashar-Oromieh, Axel Rominger
    Annals of Nuclear Medicine 2021 35 4
  • Summary of the First ISMRM–SNMMI Workshop on PET/MRI: Applications and Limitations
    Thomas A. Hope, Zahi A. Fayad, Kathryn J. Fowler, Dawn Holley, Andrei Iagaru, Alan B. McMillan, Patrick Veit-Haiback, Robert J. Witte, Greg Zaharchuk, Ciprian Catana
    Journal of Nuclear Medicine 2019 60 10
  • Head-to-head comparison between digital and analog PET of human and phantom images when optimized for maximizing the signal-to-noise ratio from small lesions
    Julien Salvadori, Freddy Odille, Antoine Verger, Pierre Olivier, Gilles Karcher, Pierre-Yves Marie, Laetitia Imbert
    EJNMMI Physics 2020 7 1
  • International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
    Patrick Veit-Haibach, Håkan Ahlström, Ronald Boellaard, Roberto C. Delgado Bolton, Swen Hesse, Thomas Hope, Martin W. Huellner, Andrei Iagaru, Geoffrey B. Johnson, Andreas Kjaer, Ian Law, Ur Metser, Harald H. Quick, Bernhard Sattler, Lale Umutlu, Greg Zaharchuk, Ken Herrmann
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 12
  • What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature
    Laura Evangelista, Luca Filippi, Orazio Schillaci
    Annals of Nuclear Medicine 2023 37 8
  • 68Ga-PSMA-11 dose reduction for dedicated pelvic imaging with simultaneous PET/MR using TOF BSREM reconstructions
    Hanna Svirydenka, Urs J. Muehlematter, Hannes W. Nagel, Gaspar Delso, Daniela A. Ferraro, Ken Kudura, Irene A. Burger, Edwin E. G. W. ter Voert
    European Radiology 2020 30 6
  • Measuring Glucose Uptake in Primary Invasive Breast Cancer Using Simultaneous Time-of-Flight Breast PET/MRI: A Method Comparison Study with Prone PET/CT
    Amy M. Fowler, Manoj Kumar, Leah Henze Bancroft, Kelley Salem, Jacob M. Johnson, Jillian Karow, Scott B. Perlman, Tyler J. Bradshaw, Samuel A. Hurley, Alan B. McMillan, Roberta M. Strigel
    Radiology: Imaging Cancer 2021 3 1
  • Dose Reduction in Brain [18F]FDG PET/MRI: Give It Half a Chance
    Marine Soret, Eve Piekarski, Nathanaëlle Yeni, Alain Giron, Jacques-Antoine Maisonobe, Maya Khalifé, Claire Zaslavsky, Marc Bertaux, Marie-Odile Habert, Aurélie Kas
    Molecular Imaging and Biology 2020 22 3

Article usage

Article usage: June 2018 to April 2025

AbstractFullPdf
Jun 2018379042
Jul 2018166018
Aug 201810705
Sep 20189003
Oct 201896012
Nov 2018134012
Dec 20181314878
Jan 2019395730
Feb 20191361616
Mar 2019146617
Apr 20198229
May 201912907
Jun 2019801319
Jul 2019721613
Aug 201935418
Sep 201953911
Oct 2019462030
Nov 201940513
Dec 201942715
Jan 202047810
Feb 20203589
Mar 2020321314
Apr 20203945
May 2020382414
Jun 202037511
Jul 202026213
Aug 20203369
Sep 20202777
Oct 202032910
Nov 20202279
Dec 20202455
Jan 2021201618
Feb 2021181828
Mar 2021101919
Apr 2021132617
May 2021201712
Jun 20218118
Jul 20214717
Aug 20218158
Sep 202141411
Oct 202161125
Nov 20219822
Dec 2021101912
Jan 2022111415
Feb 20228156
Mar 2022102014
Apr 2022111212
May 2022102414
Jun 2022108739
Jul 20225198
Aug 202222310
Sep 202211415
Oct 2022101611
Nov 202291812
Dec 202216154
Jan 2023122610
Feb 202313269
Mar 202310226
Apr 202314227
May 2023897
Jun 20233117
Jul 2023654
Aug 202310811
Sep 20236146
Oct 202391622
Nov 202364814
Dec 202321903
Jan 20242628247
Feb 20247239
Mar 202418215
Apr 2024232311
May 2024214211
Jun 2024242117
Jul 2024263215
Aug 2024405239
Sep 2024424320
Oct 2024363812
Nov 2024335724
Dec 202447385
Jan 202521309
Feb 2025207013
Mar 2025144322
Apr 2025386550
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (12)
Journal of Nuclear Medicine
Vol. 59, Issue 12
December 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI
Bert-Ram Sah, Soleen Ghafoor, Irene A. Burger, Edwin E.G.W. ter Voert, Tetsuro Sekine, Gaspar Delso, Martin Huellner, Konstantin J. Dedes, Andreas Boss, Patrick Veit-Haibach
Journal of Nuclear Medicine Dec 2018, 59 (12) 1817-1822; DOI: 10.2967/jnumed.118.209007

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI
Bert-Ram Sah, Soleen Ghafoor, Irene A. Burger, Edwin E.G.W. ter Voert, Tetsuro Sekine, Gaspar Delso, Martin Huellner, Konstantin J. Dedes, Andreas Boss, Patrick Veit-Haibach
Journal of Nuclear Medicine Dec 2018, 59 (12) 1817-1822; DOI: 10.2967/jnumed.118.209007
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology

  • Comparative PSMA expression at early (1hour) vs late (2hour) in primary and secondary sites of involvement in prostate cancer.
  • Imaging spectrum of peritoneal carcinomatosis associated with various etiologies on 18F-FDG PET/CT
  • Hybrid Imaging Features of Musculoskeletal Tumors
Show more Oncology

Clinical

  • Comparative PSMA expression at early (1hour) vs late (2hour) in primary and secondary sites of involvement in prostate cancer.
  • Imaging spectrum of peritoneal carcinomatosis associated with various etiologies on 18F-FDG PET/CT
  • Hybrid Imaging Features of Musculoskeletal Tumors
Show more Clinical

Similar Articles

Keywords

  • dose reduction
  • Positron Emission Tomography
  • Magnetic Resonance
  • Image Reconstruction
  • breast cancer
SNMMI

© 2025 SNMMI

Powered by HighWire